Economic and Market News for 20 November 2020
-
20 Nov
13:47Finsbury Growth and Income Trust issues 50,000 new sharesFinsbury Growth and Income Trust has issued 50,000 new ordinary shares of 25p from its block listing authority of 2 July 2020 at a price of 852 pence per share. The company has the ability to...
-
20 Nov
13:38Avon Rubber confirms board changesTechnology company Avon Rubber has confirmed that current chair David Evans will retire from the board on 2 December 2020, to be replaced by Bruce Thompson. Pim Vervaat will also stand down from...
-
20 Nov
13:23Princess Cruises extends pause of operations into 2021Princess Cruises is extending its pause in global operations in response to the coronavirus pandemic. It said this will allow it to prepare ships so they meet current Centers for Disease Control...
-
20 Nov
13:09Euronext shareholders approve acquisition of Borsa Italiana GroupEuronext shareholders have approved the proposed acquisition of the Borsa Italiana Group from the London Stock Exchange Group (LSEG). In preparation of the acquisition, Borsa Italiana chair Andrea...
-
20 Nov
09:50Jangada Mines says ValOre Metals releases sampling report showing high value rhodiumJangada Mines said ValOre Metals, in which the company held a 17.68% interest, released a report showing results from sampling at its Pedra Branca project showed a high value of rhodium....
-
20 Nov
09:19Advanced Medical Solutions' silicone PHMB foam dressing wins CE mark approvalSurgical and advanced wound care company Advanced Medical Solutions said it had received a CE mark approval for its silicon PHMB foam dressing, paving the way for the product to be marketed in...
-
20 Nov
09:00Block Energy to complete Schlumberger Rustaveli acquisition on 23 NovemberBlock Energy said it expected to complete the acquisition of Schlumberger Rustaveli Company on 23 November. On completion, Block would take possession of approximately 29,000 bbls of crude oil...
-
20 Nov
08:03Costain confirms appointment of Helen Willis as CFOInfrastructure solutions company Costain said it had appointed Helen Willis as chief financial officer starting 30 November. Willis would join Costain on 23 November to commence a handover prior...
-
20 Nov
08:02Alba Mineral Resources wins exploration licence for Gwynfynydd gold mine in WalesAlba Mineral Resources said it had won the exclusive exploration rights to the Gwynfynydd gold mine in north Wales. The Gwynfynydd gold mine was the second largest producer of gold in the UK's...
-
20 Nov
07:55Argentex profit slips in H1 as deferred client activity dents revenueForeign exchange services provider Argentex reported a fall in profit as clients deferred trading activity amid global market uncertainty. For the six-month period ended 30 September 2020,...
-
20 Nov
07:51ECR Minerals eyes 'accelerated push' toward exploration of HR3 prospectGold exploration and development company ECR Minerals said it would make an 'accelerated push' toward exploration work and drilling of key targets at its HR3 prospect within the Bailieston project...
-
20 Nov
07:47Diurnal wins patent in Europe for AlkindiPharmaceutical group Diurnal said it had been granted a patent for Alkindi by the European Patent Office. The patent, EP2780003, further expands the company's 'strong exclusivity position for...
-
20 Nov
07:42BBGI Global Infrastructure completes £55m equity raiseInfrastructure investment company BBGI Global Infrastructure said it had completed its equity placing, raising gross proceeds of £55.0 million. The company issued 32,544,379 shares at a price...
-
20 Nov
07:36Apax Global Alpha's Apax IX Fund sells stake in ECI Software SolutionsPrivate equity firm Apax Global Alpha said the Apax IX Fund, in which the company was a limited partner, announced that it had agreed to sell its stake in ECI Software Solutions to Leonard Green...
-
20 Nov
07:32Carnival Corporation completes equity offering to repurchase convertible notes due 2023Cruise operator Carnival said it had closed its previously announced offering of 49.2 million shares of its common stock at a price of $18.05 per share to a limited number of holders of its 5.75%...
-
20 Nov
07:17AstraZeneca's non-small cell lung cancer drug wins approval in US for additional dosing optionPharmaceutical giant AstraZeneca said its antibody imfinzi had been approved in the US for an additional dosing option to treat non-small cell lung cancer after chemoradiation therapy and...